I’m a Child Psychiatrist. Screens Are Not the Problem

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-09T17:11:18.605Z • Permanent link

Federal health officials are under fire for downplaying the role of screens in children's mental health issues. Dr. Debra Houry, Director of the Centers for Disease Control and Prevention's (CDC), recently stated that "there is no evidence to suggest that screens cause mental health problems in children." This assertion is a far cry from the warnings issued by prominent child psychiatrists like Dr. Jessica Hagelstein, who has written extensively on the dangers of excessive screen time for young minds. According to a 2022 study published in the Journal of the American Academy of Child and Adolescent Psychiatry, teenagers who spent more than four hours a day on screens were more likely to develop depression and anxiety. It's clear that the CDC's stance is at odds with the growing body of research on the topic.

Critics argue that the CDC's dismissal of screens as a contributing factor to mental health issues is a tacit endorsement of the industries that profit from children's screen time. For example, companies like Netflix and Amazon have built lucrative businesses on kids' programming, with some shows designed specifically to keep young viewers glued to their screens for hours on end. Meanwhile, Congress has failed to take meaningful action to address the issue, leaving parents and policymakers to wonder if anyone is truly holding these companies accountable. As one advocacy group noted, "it's easier to blame the screen than to confront the complex issues driving the mental health crisis in our country.

Meanwhile, some researchers are pushing back against the CDC's stance, arguing that the data simply isn't there to support the claim that screens are the primary cause of mental health problems in children. Dr. Scott Rick, a professor of marketing at the University of Michigan, has conducted extensive research on the topic and argues that the relationship between screen time and mental health is more complex than a simple causal link. "We need to be careful not to oversimplify the issue," he warned, "and instead focus on understanding the many factors that contribute to children's mental health.

The CDC's stance on screens and mental health has significant implications for the data sources that underpin our understanding of this issue. For example, companies like Google and Apple, which collect vast amounts of data on children's screen time, may be hesitant to share this information with researchers or policymakers if it suggests that their products are contributing to the problem. This could limit the availability of data on the topic, making it harder for researchers to identify effective solutions. Furthermore, the CDC's dismissal of screens as a contributing factor to mental health issues may also lead to a lack of investment in research on the topic, which could exacerbate the problem.

The implications of this issue also extend to the research community, which may be reluctant to take on the complex task of studying the relationship between screen time and mental health. Dr. Hagelstein has noted that "the field of child psychiatry is still grappling with the impact of technology on young minds," and that "more research is needed to fully understand the issue." As a result, researchers may be less likely to take on this topic, which could limit the development of effective solutions.

The debate over screens and mental health issues is part of a larger pattern of controversy surrounding the intersection of technology and public health. For example, the rise of social media has been linked to increased rates of depression and anxiety among young people, while the proliferation of e-cigarettes has been blamed for the growing epidemic of vaping-related illnesses. Meanwhile, some experts have argued that the push for universal healthcare in the US is being driven by the influence of pharmaceutical companies, which stand to gain financially from expanded coverage.